Merck Stock Price, News & Analysis
Company Description
Merck (OTC Link: MKGAF) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $55.3B.
MKGAF stock has gained 6.4% over the past year. Shares last traded at $138.51.
This page provides a comprehensive overview of MKGAF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Merck (MKGAF) stock last traded at $138.51, up 0.43% from the previous close. Over the past 12 months, the stock has gained 6.4%. At a market capitalization of $55.3B, MKGAF is classified as a large-cap stock with approximately 434.8M shares outstanding.
Latest News
Merck has 1 recent news article. Of the recent coverage, 1 article coincided with positive price movement and 0 with negative movement. View all MKGAF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Merck (MKGAF) currently stands at 1.4 million shares, up 15.0% from the previous reporting period, representing 1.1% of the float. Over the past 12 months, short interest has increased by 129.4%. This relatively low short interest suggests limited bearish sentiment. With 918.2 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Merck (MKGAF) currently stands at 918.2 days, up 49.9% from the previous period. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The ratio has shown significant volatility over the period, ranging from 99.8 to 1000.0 days.
MKGAF Company Profile & Sector Positioning
Merck (MKGAF) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing MKGAF often look at related companies in the same sector, including Merck Kgaa (MKKGY), Takeda Pharmaceutical Co Ltd (TKPHF), GALDERMA GROUP AG (GALDY), Galderma Group Ag (GDERF), and Sandoz Group AG (SDZNY). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate MKGAF's relative position within its industry.